Guardant Health/GH

$18.92

-0.26%
-
1D1W1MYTD1YMAX

About Guardant Health

Guardant Health, Inc. is a precision oncology company focused on guarding wellness and giving every person more time free from cancer. It provides critical insights into what drives disease through its advanced blood and tissue tests, real-world data, and artificial intelligence (AI) analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the best treatment for patients with advanced cancer. For patients with advanced-stage cancer, it has developed Guardant360 laboratory developed test (LDT), and Guardant360 CDx, a comprehensive liquid biopsy test to provide tumor mutation profiling with solid tumors and to be used as a companion diagnostic in connection with non-small cell lung cancer (NSCLC), and breast cancer. It offers other tests, including Guardant360 TissueNext tissue test, Guardant Reveal blood test, Guardant360 Response blood test and others.

Ticker

GH

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology & Drugs

CEO

Helmy Eltoukhy

Employees

1,779

Headquarters

Palo alto, United States

Guardant Health Metrics

BasicAdvanced
$2.31B
Market cap
-
P/E ratio
-$4.28
EPS
0.86
Beta
-
Dividend rate

What the Analysts think about Guardant Health

Analyst Ratings

Majority rating from 22 analysts.
Buy

Price Targets

Average projection from 17 analysts.
112.95% upside
High $54.00
Low $27.00
$18.92
Current price
$40.29
Average price target

Guardant Health Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-120.64% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$155M
8.39%
Net income
$-187M
117.19%
Profit margin
-120.64%
100.4%

Guardant Health Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 82.79%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$1.30
-$0.67
-$0.73
-$1.58
-
Expected
-$1.30
-$1.17
-$0.94
-$0.86
-$0.82
Surprise
-0.08%
-42.65%
-22.67%
82.79%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Guardant Health stock

Buy or sell Guardant Health stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing